Epidemiology
Aspirin Reduces Colorectal Cancer Recurrence in High-Risk Patients
Researchers from the Karolinska Institute in Stockholm, Sweden, have conducted a landmark study on the efficacy of low-dose aspirin in reducing colorectal cancer recurrence in high-risk patients. The study's findings, published in the New England Journal of Medicine, reveal that aspirin significantly lowers the incidence of colorectal cancer